Estibaliz
Estibaliz Del Cura Medina, Madrid ES
Patent application number | Description | Published |
---|---|---|
20100041644 | STABILIZED SOLID PHARMACEUTICAL COMPOSITION OF CANDESARTAN CILEXETIL - The present invention relates to a solid pharmaceutical composition containing candesartan cilexetil as active ingredient and a stabilizing agent selected from the group consisting of esters of saturated fatty acids and monohydroxy alcohols, esters of hydroxycarboxylic acids and monohydroxy alcohols, ethers of C | 02-18-2010 |
Estibaliz Fernández Pinto, Sukarrieta (vizcaya) ES
Patent application number | Description | Published |
---|---|---|
20120238489 | METHOD FOR IMPROVING FUNCTIONAL PROPERTIES BY MEANS OF PULSED LIGHT, SAMPLES WITH IMPROVED FUNCTIONAL PROPERTIES AND USES THEREOF - Disclosed is a method for improving the functional properties of a sample, which comprises at least one component that can be modified upon absorbing ultraviolet light, the method including using pulsed light with an emission spectrum of 190-1100 nm and a high content of ultraviolet light to modify the component. The method makes it possible to obtain samples with improved functional properties (hydration, glass transition, solubility, water retention capacity, oil retention capacity, thickening, dispersing, emulsifying, foaming or gelling properties, film formation properties, bulking agent properties, surface properties (wettability, adhesion, etc.)) which are used in the food industry, the cosmetics industry, the pharmaceutical industry, the biomedical industry, the biotechnological industry, the chemical industry and in other industries. | 09-20-2012 |
Estibaliz Ochoteco Vaquero, San Sebastian (guipuzcoa) ES
Patent application number | Description | Published |
---|---|---|
20120181173 | ELECTROCHEMICAL SENSOR FOR THE DETECTION OF ANALYTES IN LIQUID MEDIA - The invention relates to an electrochemical sensor for the detection of analytes in liquid media which comprises 4 layers, wherein the first layer (1) comprises a carbonaceous material deposited on a substrate, said layer forming the system of electrodes of the electrochemical sensor, formed at least by a pseudo-reference electrode, a working electrode and a counter electrode; and the fourth layer (4) comprises polythiophene deposited only on the lower end of the working electrode selected from (d1), which comprises a layer comprising a polythiophene deposited on the lower end of the working electrode and a layer comprising a non-conductive polymer gel deposited on said layer of polythiophene; (d2), which is a layer of conductive polymer gel comprising a non-conductive polymer gel and a polythiophene; and (d3), which comprises a layer comprising a polythiophene deposited on the lower end of the working electrode and a layer comprising functionalized magnetic nanoparticles deposited on said layer of polythiophene. | 07-19-2012 |
Estibaliz Olano Martin, Derio ES
Patent application number | Description | Published |
---|---|---|
20140315737 | BIOMARKERS FOR EPILEPSY - The present invention relates to a group of epilepsy biomarkers comprising (i) SNP rs2740574; (ii) SNP rs1799735; (iii) SNP rs1695; (iv) SNP rs6280; and the locus of the human glutathione S-transferase theta-1 (GSTT1) gene. The invention particularly relates to this group of biomarkers as marker for protection against drug-resistant epilepsy. The group of biomarkers may additionally comprise at least one clinical marker selected from the group comprising (i) a focal seizure with secondary generalization; (ii) age at confirmed diagnosis of epilepsy; (iii) atrophy of hippocampus or medial temporal sclerosis; and (iv) the presence of a brain tumor. The present invention further relates to a method for detecting protection against drug-resistant epilepsy in a subject, a method for monitoring epilepsy therapy, a method of identifying an individual as eligible for an aggressive epilepsy therapy, a composition for detecting protection against drug-resistant epilepsy in a subject, a corresponding kit and a microarray for the analysis of protection against drug-resistant epilepsy. | 10-23-2014 |